
Kamila Valieva’s figure skating fate could remain unresolved until at least the end of the year after the Court of Arbitration for Sport announced it will hear simultaneous appeals at its head office in Lausanne in September.
It is over 16 months since Valieva learned she had tested positive for the banned heart drug Trimetazidine at the Winter Olympics in Beijing, and medals for the team competition, in which the then 15-year-old helped Russia win gold, are yet to be awarded.